Article Text

Download PDFPDF

Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis
  1. J-C Lega1,2,
  2. Y Lacasse1,
  3. L Lakhal1,3,
  4. S Provencher1
  1. 1
    Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec (Hôpital Laval), Québec, Canada
  2. 2
    Service de médecine interne et de pathologie vasculaire, Centre Hospitalier Lyon Sud, Université Claude Bernard Lyon 1, Lyon, France
  3. 3
    Département de mathématiques et statistique, Université Laval, Québec, Canada
  1. Correspondence to Dr S Provencher, Centre de Pneumologie, Hôpital Laval, 2725 Chemin Ste-Foy, Québec, P Québec, G1V 4G5 Canada; steve.provencher{at}crhl.ulaval.ca

Abstract

Background: The role of biomarkers such as B-type natriuretic peptides (BNP and NT-proBNP) and troponins in risk stratification of acute pulmonary embolism (APE) is still debated. A meta-analysis was performed to assess the association between raised natriuretic peptide levels, alone or in conjunction with troponins, and all-cause and APE-related mortality, serious adverse events and echographic right ventricular dysfunction.

Methods: MEDLINE and EMBASE databases were searched and conference abstracts were hand searched up to February 2008. Studies were included if a 2×2 table could be constructed based on natriuretic peptide results and at least one of the outcomes.

Results: Twenty-three studies were included (1127 patients). Raised natriuretic peptide levels were significantly associated with all-cause mortality (odds ratio (OR) 6.2; 95% confidence interval (CI) 3.0 to 12.7), APE-related mortality (OR 5.0; 95% CI 2.2 to 11.5) and serious adverse events (OR 6.7; 95% CI 3.9 to 11.6), with homogeneity across studies. Among patients with raised natriuretic peptide levels, increased serum troponins were associated with a further increase in the risk of adverse outcomes. Analysis of the accuracy of natriuretic peptides in detecting right ventricular dysfunction was limited by heterogeneity across studies. BNP appeared to have better sensitivity and specificity than NT-proBNP in detecting right ventricular dysfunction.

Conclusions: Raised levels of B-type natriuretic peptides identified a subset of patients with APE at higher risk of adverse outcomes. Among patients with raised natriuretic peptide levels, increased troponins were found to be an independent prognostic marker. The results of this meta-analysis may have important clinical implications in the management of APE.

View Full Text

Statistics from Altmetric.com

Supplementary materials

Footnotes

  • Funding A scholarship fund was provided by the Ministère français de l’Éducation nationale, de l’Enseignement supérieur et de la Recherche. The Ministère was not otherwise involved in the study.

  • Competing interests None.

  • Provenance and Peer review Not commissioned; externally peer reviewed.

  • See Editorial, p 833

  • ▸ Details of the search strategy and additional tables and figures are published online only at http://thorax.bmj.com/content/vol64/issue10

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles